Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)
January 31, 2024 08:00 ET
|
Lophos Holdings Inc.
NAPANEE, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation
January 23, 2024 10:23 ET
|
Lophos Holdings
NAPANEE, Ontario, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (“Lophos”) (CSE:MESC), a trailblazer in the production of Lophophora williamsii (peyote), proudly announces a significant...
Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions
November 21, 2023 19:00 ET
|
Lophos Holdings
NAPANEE, Ontario, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is delighted to share additional information on its wholly-owned subsidiary, Lophos...
Lophos Secures Game-Changing Controlled Substance Dealer's License with the Expertise of Canalytica Corp.
October 10, 2023 08:00 ET
|
Lophos Holdings
Lophos Pharmaceuticals Corp. obtains a Controlled Substance Dealer’s License from Health Canada.
Lophos Opens Early Enrollment for Peyote Sales and Appoints Market Maker
September 19, 2023 07:00 ET
|
Lophos Holdings
VANCOUVER, British Columbia, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is delighted to share a substantial milestone. Its wholly owned...
Lophos Announces Listing on the Canadian Securities Exchange
August 31, 2023 09:57 ET
|
Lophos Holdings
VANCOUVER, British Columbia, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") is pleased to announce that its common shares have been approved for listing on the...
Lophos Pharmaceuticals Receives Controlled Substances Dealers License (CSDL) From Health Canada
August 25, 2023 08:44 ET
|
Lophos Holdings
NAPANEE, Ontario, Aug. 25, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. is pleased to announce that its wholly owned subsidiary, Lophos Pharmaceuticals Corp., has received its Controlled Substances...
Lophos Pharmaceuticals Submits Application for Controlled Drugs and Substances Dealer’s License
February 17, 2022 08:00 ET
|
Lophos Holdings
TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Lophos Holdings (The “Company”) is pleased to provide an update on its wholly owned subsidiary Lophos Pharmaceuticals (“Lophos”). Lophos is a psychedelic...
G2 Acquires Lophos Pharma, a peyote focused psychedelics company
January 21, 2022 14:38 ET
|
Greenridez 2.0 Acquisitions Corp.
TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Greenridez 2.0 Acquisitions Corp. (the "Company") is pleased to announce that it has completed its acquisition of psychedelic research company Lophos...